Recro Pharma, Inc. Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Recro Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Recro Pharma, Inc. for December 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 19 2014 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | LUDOMIRSKI ABRAHAM | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Garner Charles | CFO and Chief Busin ... | Option Exercise | A | 2.47 | 23,000 | 56,810 | 23,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Garner Charles | CFO and Chief Busin ... | Option Exercise | A | 2.47 | 23,000 | 56,810 | 23,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Mack Randall | Senior VP, Developm ... | Option Exercise | A | 2.47 | 19,000 | 46,930 | 19,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Mack Randall | Senior VP, Developm ... | Option Exercise | A | 2.47 | 19,000 | 46,930 | 19,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | CHURCHILL WINSTON J | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Weisman Wayne | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Myers Diane | Senior VP-Reg/Quali ... | Option Exercise | A | 2.47 | 18,000 | 44,460 | 18,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Myers Diane | Senior VP-Reg/Quali ... | Option Exercise | A | 2.47 | 18,000 | 44,460 | 18,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Berelowitz Michael | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Nichols Donna | CAO/Controller | Option Exercise | A | 2.47 | 10,500 | 25,935 | 10,500 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | Nichols Donna | CAO/Controller | Option Exercise | A | 2.47 | 10,500 | 25,935 | 10,500 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | ALTOMARI ALFRED | Director | Option Exercise | A | 2.47 | 22,000 | 54,340 | 22,000 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Option Exercise | A | 2.47 | 123,500 | 305,045 | 123,500 | |
Dec 19 2014 | REPH | Recro Pharma, Inc. | HENWOOD GERALDINE | President and CEO | Option Exercise | A | 2.47 | 123,500 | 305,045 | 123,500 | |
Dec 04 2014 | REPH | Recro Pharma, Inc. | Broadfin Healthcare Master Fun ... | 10% Owner | Buy | P | 2.50 | 241,338 | 603,345 | 1,413,533 | 1.2 M to 1.4 M (+20.59 %) |